James Ted A, Wade Jacqueline E, Sprague Brian L
College of Medicine, University of Vermont, Burlington, Vermont.
Department of Surgery, University of Vermont Medical Center, Burlington, Vermont.
J Surg Oncol. 2016 Apr;113(5):496-500. doi: 10.1002/jso.24184. Epub 2016 Jan 22.
Mammographic screening has been shown to result in downward stage migration, reflected by smaller tumor sizes and less extensive nodal involvement. National guidelines restrict screening recommendations in women age 40-49. The purpose of this study is to evaluate the specific impact of mammographic screening patterns on the surgical management of breast cancer in women aged 40-49.
The study is a population-based retrospective review of the Vermont Breast Cancer Surveillance System of women aged 40-49 with a diagnosis of breast cancer. Tumor stage and related characteristics at the time of diagnosis, as well as the type of surgical intervention performed were recorded for women presenting with screen-detected versus non-screen-detected breast cancer.
Screen-detected breast cancers in women aged 40-49 were associated with a greater incidence of DCIS, smaller invasive tumor size, fewer cases of positive nodes, and higher rates of breast conservation compared to non-screened women presenting with symptomatic disease.
Mammographic screening is associated with less aggressive surgical treatment of breast cancer including higher rates of breast conservation. The observed changes in surgical management should factor into individual decision-making regarding screening mammography. J. Surg. Oncol. 2016;113:496-500. © 2016 Wiley Periodicals, Inc.
乳腺钼靶筛查已显示可导致分期下移,表现为肿瘤尺寸更小且淋巴结受累范围更小。国家指南限制了对40 - 49岁女性的筛查建议。本研究的目的是评估乳腺钼靶筛查模式对40 - 49岁女性乳腺癌手术治疗的具体影响。
本研究是对佛蒙特州乳腺癌监测系统中40 - 49岁确诊为乳腺癌的女性进行的基于人群的回顾性研究。记录了筛查发现的乳腺癌患者与非筛查发现的乳腺癌患者在诊断时的肿瘤分期及相关特征,以及所进行的手术干预类型。
与出现症状性疾病的未筛查女性相比,40 - 49岁筛查发现的乳腺癌与导管原位癌(DCIS)发病率更高、浸润性肿瘤尺寸更小、阳性淋巴结病例更少以及保乳率更高相关。
乳腺钼靶筛查与乳腺癌手术治疗侵袭性降低相关,包括更高的保乳率。手术治疗中观察到的变化应纳入关于乳腺钼靶筛查的个体决策中。《外科肿瘤学杂志》2016年;113卷:第496 - 500页。© 2016威利期刊公司